GHK-Cu myths: what the research does not show
GHK-Cu is a copper-binding tripeptide with a deep record of cell and animal research, one positive randomized wound trial from 1994, and very few controlled human studies on skin ageing or hair. This page checks the best-known claims against that record, one at a time.
Findings
- In a randomized, evaluator-blinded trial in diabetic foot ulcers, a GHK-Cu gel gave a median 98.5% wound closure against 60.8% for the vehicle gel (Wound Repair Regen, 1994).
- The same trial reported ulcer infection in 7% of treated ulcers against 34% with vehicle.
- In cultured lung cells, GHK reversed a gene-expression pattern linked to emphysema tissue damage (Genome Med, 2012).
- The biggest gap: a 2025 review of GHK as an anti-wrinkle ingredient found almost no controlled human studies of GHK-Cu in skin.
View product →Myth: GHK-Cu is proven to erase wrinkles
Not proven. Cell studies show GHK raises collagen and related skin proteins, and a 2025 review accepted it as an anti-wrinkle ingredient on that cellular basis. The same review found almost no human studies to back it. In a small randomized study after laser skin resurfacing, with 13 people completing it (2006), blinded evaluators found no difference in wrinkles or redness between GHK-Cu skin care and the comparison regimen, though participants using GHK-Cu rated their skin quality higher.
Myth: GHK-Cu regrows hair
The most-cited hair study did not use GHK-Cu. The 2007 paper tested AHK-Cu, a close relative, on human hair follicles kept alive in the laboratory, and found longer follicle growth and less cell death. That is a useful lead for laboratory research. We found no controlled human trial of GHK-Cu on its own for hair loss, so “regrows hair” is ahead of the evidence.
Myth: GHK-Cu resets thousands of your genes to a younger state
This claim comes from computer analysis of gene-expression databases, mostly built on cell lines. In 2012, researchers used such a database to flag GHK as a compound that could reverse a lung-damage gene pattern, then confirmed effects in cultured lung fibroblasts. Later reviews by Pickart and colleagues described it as resetting genes to a healthier state. None of this measured gene activity in living people given GHK-Cu.
Myth: GHK-Cu heals wounds
Partly true, and this is its strongest human result. In the 1994 multicentre trial in diabetic foot ulcers, a GHK-Cu gel used alongside standard wound care closed ulcers further and faster than the vehicle gel, and infections were less frequent. It was a single trial of a topical gel in one wound type, and it is more than 30 years old. Strong for that setting; not a general healing claim.
Myth: GHK-Cu repairs ligaments and joints
The joint evidence is one rat study. In 2015, 72 rats had a reconstructed knee ligament and received GHK-Cu or saline into the joint. At six weeks the GHK-Cu groups had less knee laxity, but by twelve weeks there was no difference, and the load the graft could take before failing never differed. The authors called the benefit transient. There is no human joint data.
Myth: GHK falls with age, so topping it up reverses ageing
The first half has support. GHK is found in human plasma, saliva and urine, and reviews report that its levels decline with age. The second half does not follow. No published study has raised GHK levels in people and then measured a slowing or reversal of ageing.
What GHK-Cu cannot promise
GHK-Cu is one of the most studied peptides at the cell level, and that is the level most of its claims come from.
- It cannot promise fewer wrinkles; controlled human skin data are close to absent.
- It cannot promise hair regrowth; the key follicle study used a different peptide.
- It cannot promise gene “resetting” in a living person; that was never measured.
- It cannot promise joint or ligament repair; the one rat benefit faded.
Where the evidence stands
GHK-Cu is not an approved medicine in Canada for any use. It appears in cosmetic products, and as a research compound it has strong laboratory data, a single positive wound-healing trial and a few small human skin reports. As sold by research suppliers, it is a material for laboratory research.
Vistara Labs supplies GHK-Cu as a laboratory research material. The page above is about the published research, not a claim about our product.
Frequently asked questions
Has GHK-Cu been tested in human trials?
A few times. The clearest is a 1994 randomized trial in diabetic foot ulcers, where a GHK-Cu gel gave a median 98.5% closure against 60.8% for vehicle. Controlled human studies on skin ageing and hair are scarce.
Does GHK-Cu regrow hair?
That has not been shown in a controlled human trial. The often-cited follicle study used a related peptide, AHK-Cu, on follicles in the laboratory.
Is it true that GHK-Cu changes gene expression?
In cell studies, yes. A 2012 study found GHK reversed a lung-damage gene pattern in cultured cells. This has not been measured in people.
Sources: Mulder GD, Patt LM, Sanders L, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994. PMID 17147644. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. Bioimpacts. 2025. PMID 39963574. Miller TR, Wagner JD, Baack BR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006. PMID 16847171. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007. PMID 17703734. Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012. PMID 22937864. Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014. PMID 25302294. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015. PMID 26236730. Fu SC, Cheuk YC, Chiu WY, et al. Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction. J Orthop Res. 2015. PMID 25731775.
All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.
References
The stronger human GHK-Cu evidence is topical and wound-related. It does not establish effects for systemic or injectable use, and one randomised cosmetic study found no objective advantage.
- Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copperMulticentre randomised, evaluator-blinded, placebo-controlled trial; topical GHK-Cu in diabetic neuropathic ulcers.
- Effects of topical copper tripeptide complex on CO2 laser-resurfaced skinRandomised trial after CO2 laser resurfacing; 13 patients completed. No significant objective advantage found for erythema, wrinkles or overall skin quality.
Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.
